NCT05317806View on ClinicalTrials.gov

Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Plasminogen Activator Inhibitor-1 DeficiencyCardiac Fibrosis
Interventions
DRUG

Metformin Extended Release Oral Tablet

daily metformin treatment vs. no treatment with metformin

Trial Locations (1)

46260

Indiana Hemophilia and Thrombosis Center, Indianapolis

All Listed Sponsors
lead

Indiana Hemophilia &Thrombosis Center, Inc.

OTHER

NCT05317806 - Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency | Biotech Hunter | Biotech Hunter